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ABSTRACT
Tagitinin C, an active constituent of Tithonia diversifolia (Hemsley) A. Gray, has 
been proven caninhibit the collagen deposition of keloid fibroblasts in vitro. 
However, its mechanism of action has not been widely studied. One possible 
mechanism involves growth factors and cytokines. Vascular endothelial growth 
factor (VEGF) and tumor necrosis factor alpha (TNF-α) play an important role 
in the collagen deposition. The study aimed to evaluate the effect of tagitinin C 
on VEGF and TNF-α expression in keloid fibroblasts culture. An experimental 
laboratory study using fibroblast cell lines at passages III and IV was performed. 
Treatments were divided into two groups i.e. the treatment groups after 
incubation with tagitinin Cat various concentration of 1, 0.5, 0.25, and 0.125μg/
mL for 72 h, and the control group using culture media without tagitinin C. 
Following after incubation, the VEGF and TNF-α levels of keloid fibroblast 
culture supernatant were measured by ELISA. Kruskal-Wallis test continued 
using Mann-Whitney test or one way Anova continued by independent t test 
were applied to evaluate the differences between groups. A p value of less 
than 0.05 was considered statistically significant. The VEGF levels significantly 
decreases in concentration-dependent manner after treatment of the tagitinin 
C at various concentrations (p<0.05). However, no significantly difference in 
TNF-α levels was observed (p> 0.05). In conclusion, tagitinin C decreases the 
VEGF expression of keloid fibroblasts. However, it has no effect on the TNF-α 
expression.
ABSTRAK
Tagitinin C, suatu senyawa aktif dari Tithonia diversifolia (Hemsley) A. Gray, 
telah terbukti dapat menghambat deposisi kolagen fibroblas keloid secara in 
vitro. Namun mekanismenya belum banyak dikaji. Salah satu kemungkinan 
mekanisme aksinya adalah melalui keterlibatan factor pertumbuhan dan 
sitokin. Vascular endothelial growth factor (VEGF) dan tumor necrosis factor 
(TNF-α ) memegang peranan penting dalam deposisi kolagen. Penelitian ini 
bertujuan mengkaji efek tagitinin C terhadap ekspresi VEGF dan TNF-α pada 
kultur fibroblas keloid. Ini merupakan penelitian eksperimental laboratorium 
menggunakan sel fibroblas keloid pada sub kultur ke III dan IV. Perlakuan 
dibagi dua kelompok yaitu kelompok perlakuan setelah perlakuan dengan 
tagitinin C dengan konsentrasi 1; 0,5; 0,25 dan 0;125μg/mL selama 72 jam, dan 
kelompok control hanya menggunakan sel fibroblast keloid tanpa tagitinin C. 
Setelah inkubasi, kadar VEGF dan TNF-α dalam supernantan kultur fibroblast 
keloid ditetapkan dengan ELISA. Uji Kruskal-Wallis dilanjutkan dengan uji 
Mann-Whitney atau Anova satu jalan dilanjutkan dengan uji t independent 
digunakan untuk mengkaji perbedaan antar kelompok. Nilai p lebih kecil 
dari 0,05 dianggap berbeda nyata. Kadar VEGF turun tergantung konsentrasi 
setelah perlakuan tagitinin C pada berbagai konsentrasi (p<0.05). Namun 
demikian, perbedaan tidak nyata pada kadar TNF-α dapat diamati (p>0,05). 
Dapat disimpulkan, tagitinine C menurunkan ekspresi VEGF fibroblas keloid, 
namun tidak mempunyai efek pada ekspresi TNF-α.
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INTRODUCTION
Keloids are harmless fibroprolife 
ration dermal tumors that growin the scar 
and exceed the  wound  limit. Keloid is 
characterized by excessive accumulation 
of extracellular matrix components 
such as collagen, fibronectin, elastin, 
proteoglycans and growth factors.1 
Keloid incident has a correlation 
with the wound healing process. The 
abnormal process of wound healing 
from the formation and degradation 
of matrix proteins, the expression of 
cytokines, growth factors and apoptosis 
pathways greatly affect the potential for 
hypertrophy scars to keloid.2
Vascular endothelial growth 
factor (VEGF) belongs to the group of 
growth factors that  participates  in 
the angiogenic response by increasing 
microvascular permeability, inducing 
endothelial cell (EC) proliferation, 
migration, survival and secretion of 
matrix metalloproteinases (MMPs).3 
It also plays an important role in the 
formation of keloids by changing the 
extracellular matrix and increasing EC 
proliferation.4
Deregulated cytokine secretion 
is implicated in several disease states 
ranging from chronic inflammation. 
When macrophages are exposed to 
inflammatory stimuli, they secrete 
cytokines such as tumor necrosis factor 
(TNF), interleukin-1 (IL-1), IL-6, IL-
8, and IL-12. All of these molecules, 
in concert, may inducein creased 
vascular permeability and recruitment 
of inflammatory cells. For example, 
excessive production of IL-1β and 
TNF triggers an acute generalized 
inflammatory response.5  Large amounts 
of TNF-α involve nuclear factor kappa-
light-chain-enhancer of activated B 
cells (NF-κB) and stimulate MMPs in 
wound healing and angiogenesis to 
tumor metastasis by inhibiting caspase 
8 in the process of apoptosis in keloid 
fibroblasts.6
Patients prone to healing problems 
should receive preventive treatment. 
These preventions usually include 
topical medical application, cryotherapy, 
the use of silicone gel sheets, the injection 
of steroids, radio therapy and an early 
surgical procedure for wound closure.7 
Recent reports have introduced the use 
of extracts from natural sources such as 
plant extracts in an attempt to correct 
these problems. One alternative therapy 
that could be applied is kembang bulan 
[Tithonia diversifolia (Hemsley) A. Gray]. 
The potency of kembang bulan as an 
anticancer agent has been investigated. 
Ethyl acetate extract of kembang 
bulan has cytotoxic effects and induce 
apoptosis in human hepatoma HepG2 
cells.8 Chloroform extract from the T. 
diversifolia plant has also been reported 
to inhibit the proliferation of other 
cancer cells (WiDr cell line).9 Ethanolic 
extract of  T. diversifolia as an antifibrosis 
agent was proven with its capability 
to inhibit the proliferation  of keloid 
fibroblasts and collagen accumulation.10 
In addition, ethanolic extract of  T. 
diversifolia inhibits fibroblast migration 
activity, decreases the transforming 
growth factor-beta1 (TGF-β1), and 
inhibits vascular endothelial growth 
factor (VEGF) expression of keloid 
fibroblasts.11
Tagitinin C, is an active substance 
isolated from T. diversifolia. It is a 
sesquiterpene lactone (SLS) class that 
shows cytotoxicity against cancer 
cells. Tagitinin C also inhibits collagen 
accumulation on keloid fibroblasts in 
vitro after 72 and 120 h of incubation.12 
Tagitinin C also inhibits the fibroblast 
migration activity and decrease TGF-β1 
levels of keloid fibroblasts.13 This study 
was conducted to evaluate the effect 
of tagitinin C on the VEGF and TNF-α 
expressions of keloid fibroblast culture.
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MATERIALS AND METHODS
MATERIALS
This was an experimental laboratory 
study conducted at the Laboratory 
of Health Technology, Department of 
Dermatology and Venerology, Faculty 
of Medicine Public Health and Nursing, 
Universitas Gadjah Mada/Dr. Sardjito 
General Hospital, Yogyakarta. The 
protocol of the study was approved by 
the Medical and Health Research Ethics 
Committee, Faculty of Medicine Public 
Health and Nursing, Universitas Gadjah 
Mada/Dr. Sardjito General Hospital (ref. 
KE/FK/426/EC). Tagitinin C was isolated 
from the leaves of T. diversifolia as 
conducted based on previous studies.10 
The chemical structure of tagitinin C is 
presented in FIGURE 1.14
FIGURE 1. chemical structure of tagitinin C
Keloid fibroblasts and normal 
fibroblasts were obtained from the 
Laboratory of Health Technology, 
Department of Dermatology and 
Venereology, Faculty of Medicine, Public 
Health and Nursing, Universitas Gadjah 
Mada/Dr. Sardjito General Hospital. 
Keloid fibroblast and normal fibroblast 
cell lines were maintained in vitro in 
Dulbecco’s modified eagle medium 
(DMEM). The primary culture was 
harvested after all petri fibroblasts were 
examined by inverted microscopy. The 
next step was subculture processing. The 
whole subculture process was repeated 
with sterile PBS for washing, DMEM for 
medium, and 2 mL 0.25% trypsin for 
trypsinization until mature subculture 
at passage III-IV.
Determination of the inhibition 
concentration 50% (IC50) of tagitinin C
The IC50 of tagitinin C on keloid 
fibroblast was determined using MTT 
assay. The IC50would be determined 
tagitinin C concentration on the VEGF 
and TNF-α expressions study. Keloid 
fibroblast cells were distributed in 
96-wells microplates at 1 x 104 cells 
per well in 200 μL of complete DMEM 
medium. The cell cultures were then 
incubated in 5% CO2 incubator at 37
oC 
for 24 h. Followed after incubation, the 
medium was removed and replaced with 
new complete DMEM medium containing 
various concentrations of tagitinin C i.e. 
1, 0.5, 0.25, 0.125, 0.0625, and 0.03125 
μg/mL in triplicate. The DMEM medium 
just containing keloid fibroblast was 
used as negative control. After wards, 
the cell cultures containing tagitinin 
C were incubated again for 3 days. 
After the incubation, the medium was 
removed and the cells were resuspended 
in DMEM medium, 10 µL of 5 mg/mL 
MTT [3-9, 4, 5-dimethylthiazole-2-yl-2,5-
diphenyltetrazolium bromide] and then 
further incubated for 4 h. The reaction 
was stopped by adding 100 µL of 10% 
sodium dodecyl sulfate (SDS) in 0.01N 
HCl. The 96-well microplate was then 
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shaken gently for 5 min, covered with 
aluminum foil and incubated at room 
temperature overnight. Absorbance of 
the 96-well microplate was measured in 
an ELISA plate reader at λmax 595 nm. The 
IC50 values were determined by probit 
analysis.
Measurement of VEGF and TNF-α 
levels
The keloid fibroblast culture 
supernatant from the IC50 experimental 
result. e. was stored for further 
measurement of VEGF and TNF-α levels 
using ELISA reader. The VEGF and 
TNF-α levels were measured according 
to the protocol issued by Koma Biotech 
Inc. as a manufacturer of measurement 
kits for human VEGF (Catalog number : 
K0331132) and TNF-α (Catalog number 
K0331131).
Statistical analysis
Data of VEGF and TNF-α levels 
were presented as mean ± standard 
deviation (SD). The VEGF levels between 
groups were analyzed by using Kruskal-
Wallis test continued using Mann-
Whitney test, where as the TNF-α levels 
between groups were analyzed by using 
one way analysis of variance (ANOVA) 
continued by independent t test. A 




The IC50 of tagitinin C against 
keloid fibroblast growth obtained in 
this study was 0.384μg/mL. Therefore, 
the measurement of VEGF and TNF-α 
levels on the keloid fibroblast culture 
supernatant was performed at the 
tagitinin C concentrations of 0.125, 
0.25, 0.5 and 1 μg/mL. The results of 
the measurement of VEGF levels are 
presented in FIGURE 2 and TABLE 1. The 
VEGF levels significantly decreases after 
treatment of the tagitinin C at various 
concentrations (p<0.05). It demonstrated 
that the tagitinin C inhibits the VEGF 
expression of the keloid fibroblast.
FIGURE 2. The VEGF levels on keloid fibroblast culture supernatant 
after tagitinin C treatment.
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TABLE 1. Mean VEGF and TNF-α expression supernatant by treatment group
Variable KF KF+TG0.125 KF+TG0.25 KF±TG0.5 KF±TG1 NF p
VEGF(ρg/mL) 222.9±3.6 142.2±2.0 117.3±2.7 108.9±2.5 75.7±3.6 20.2±0.6 <0.05
TNF-α (ρg/mL) 2.4±0.5 2.7±0.9 3.0±1.7 3.1±1.8 3.7±1.4 3.1±1.1 <0.05
KF: keloid fibroblast; KF+TG1:keloid fibroblast + tagitinin 1 μg/mL; KF+TG0.5: keloid 
fibroblast + tagitinin 0.5 μg/mL; KF+TG0.25: keloid fibroblast +tagitinin 0.25 μg/mL; 
KF+TG0.125: keloid fibroblast + tagitinin 0.125 μg/mL; NF: normal fibroblast.
FIGURE 3. The TNF-α levels on keloid fibroblast culture supernatant 
after tagitinin C treatment.
DISCUSSION
VEGF is a cytokine proangiogenesis 
that plays an important role in normal 
conditions as well as wound healing, 
including pathology. VEGF angiogenic 
peptides have various isoforms, and 
VEGF is also a vascular permeability 
factor that promotes neovascularization 
and growth cells.15 The lower VEGF 
expression in normal fibroblasts 
indicated that the production of VEGF 
by normal fibroblasts was affected by 
the condition of the cell. VEGF increases 
granulation tissue and promotes 
keratinocyte migration.16 Keratinocytes 
also participate in abnormal wound 
healing processes, leading to the 
formation of keloid scars with increased 
proliferation.17
Increased expression in keloid 
fibroblasts was caused by local hypoxic 
conditions, which also contributed to the 
increased expression of VEGF in keloid 
fibroblasts with the accumulation of high 
HIF-1.18 Hypoxia can induce cytokine 
expression and the production of growth 
factors released by macrophages, 
keratinocytes, and fibroblasts. Cytokines 
that are produced in response to hypoxia 
include PDGF, TGF-𝛽, VEGF, TNF-𝛼, and 
endothelin-1, which are promoters of 
TNF-α levels
The results of the measurement 
of TNF-α levels are presented in 
FIGURE 3 and TABLE 1. The TNF-α 
levels after tagitinin C treatment were 
not significantly different compared 
to that fibroblast keloid and normal 
fibroblast (p>0.05). It demonstrated that 
the tagitinin C did not affect the TNF-α 
expression of the keloid fibroblast.
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cell proliferation, migration, chemotaxis, 
and angiogenesis.19 HIF-1, the major 
transcription factor in response to 
hypoxia, is a heterodimeric molecule of 
2 subunits, HIF-1α and HIF-1β. HIF-1α 
has an oxygen-dependent degradation 
domain, and its expression and 
activity are regulated by the cellular 
oxygen concentration, while HIF-1β is 
constitutively expressed. HIF-1α binds 
to DNA on hypoxia response elements 
(HREs) in promoters of more than 60 
target genes, such as VEGF and MMPs, 
many of which are involved in keloid 
formation.20
Fibrosis in phase keloid tissue caused 
by increased exogenous and endogenous 
VEGF in keloid fibroblasts. Exogenous 
VEGF will increase by VEGF receptors, 
whereas endogenous VEGF will increase 
with increased transcription factor VEGF 
and IGF in tissue keloid fibroblasts.4 
VEGF is a pro-angiogenic growth factor 
that increases keloid tissue angiogenesis, 
chronic inflammation occurs and 
persistently increases fibroblast 
proliferation.
This study showed that tagitinin 
C significantly decrease the VEGF 
expression of keloid fibroblast in a 
dose-dependent manner (FIGURE 2 and 
TABLE 1). At the highest concentration 
of tagitinin C (1 μg/mL), the VEGF levels 
reached 75.7 ± 3.6pg/mL. At the lowest 
concentration of tagitinin C (0.125 μg/
mL) the VEGF levels (142.2 ± 2.0pg/mL) 
was still significantly lower than the 
VEGF levels of keloid fibroblast (222.9 ± 
3.6 pg/mL) indicating its effecthas been 
observed. 
This studys howed that tagitinin C 
might inhibit the proliferation of keloid 
fibroblast cells through the inhibition 
of the VEGF expression. It might 
inhibit the formation of a transcription 
factor of endogenous VEGF in keloid 
fibroblasts. VEGF is abundant in the 
dermis underlying keloids. In vitro 
studies showed that VEGF is expressed 
at high levels in keloid fibroblasts 
derived from normal skin fibroblasts.21 
Therefore, administration of tagitinin 
C could decrease VEGF production to 
effectively inhibit the formation of new 
extracellular matrix via inhibition of 
the VEGF pathway, signaling on the 
proliferation of keloid fibroblast tissue. 
Investigation of other growth factors 
can be performed to find another path 
that can be traversed by tagitinin C 
in the inhibition of keloid fibroblast 
proliferation. Derivatives such as platelet 
growth factor (PDGF) also play a role 
in increasing collagen production and 
synthesis of new extracellular matrix. 
PDGF receptors are also produced greatly 
in keloid fibroblasts.22
The effect of tagitinin C on TNF-α 
expression in the keloid fibroblast 
cultures was also investigated in 
this study. Tumor necrosis factor-
alpha, a proinflammatory cytokine, 
is an important mediator during the 
inflammatory phase of wound healing. 
Excessive amounts of the TNF-α are 
closely associated with an increase in 
inflammatory diseases such as chronic 
wounds. TNF-α stimulates the secretion 
of active MMP-2 and type IV collagenase 
in organ culture, which affects the 
thickness of human skin. The excessive 
amounts of TNF-α causes the activation 
of NF-κB, which stimulates MMPs 
during wound healing. It also stimulates 
angiogenesis to tumor metastasis by 
inhibiting caspase 8 during the apoptosis 
process that closely connected with the 
potential increase in keloids.6
TNF-α expression of the keloid 
fibroblast control (2.4±0.5pg/mL) 
compared to the normal fibroblast 
(3.1±1.1pg/mL) was not significantly 
different (TABLE 1; p>0.05). It was 
indicated that the keloid process does not 
affect the TNF-α expression. Fibroblast 
cell proliferation during keloid process 
was not associated with the TNF-α 
expression. Furthermore, the tagitinin C 
administration did not affect the TNF-α 
expression. The TNF-α levels in keloid 
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fibroblast cells culture after exposure 
of various concentration (0.125 – 1 μg/
mL) of taginitin C were not significantly 
different (p>0.05). 
CONCLUSION
Tagitinin C decreases the VEGF 
expression in keloid fibroblasts. 
However, it has no effect on the TNF-α 
expression.
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